BEBT-209
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for BEBT-209, covering 2024-11-13 to 2026-04-22. Get the full timeline:
Most recent: Clinical Trial Update: A Study of BEBT-209 Plus Chemotherapy in Patients With Locally Advanced or Metastatic Triple-Negative Breast Cancer [Phase 2, Phase 3]